Clinical trial
Samba-02: An Investigation of the Dose-Response and Subject Variability of Inhaled Insulin in Subjects with Type 2 Diabetes
The main objectives are :
- Assessment of the linearity of the dose response curves (based on AUCINS,0-?, CMAX,INS, AUCGIR,0-12h and GIRMAX) of inhaled insulin
- Comparison of the inter- and intra-subject variability (based on AUCINS,0-?, CMAX,INS, AUCGIR,0-12h and GIRMAX) of inhaled insulin with subcutaneous insulin (Humalog�, insulin lispro) administration
Category | Value |
---|---|
Study start date | 2013-07-29 |